Navigation Links
Market Demand and Innovation in Germany Propel Industrial Biotechnology Growth
Date:6/25/2010

BERLIN, June 25, 2010 /PRNewswire/ -- Industrial biotechnology is expected to grow worldwide by 10 to 20 percent per year through 2020. Germany has already established the preconditions to accelerate R&D and commercialization in this nascent industry, making it an ideal site for companies looking to benefit from growing market demand. Representatives from Germany Trade & Invest will be on hand at this year's World Congress on Industrial Biotechnology & Bioprocessing, taking place from June 27 - 30 in Washington, DC, to discuss business opportunities in Germany.

More than 40 percent of small and medium enterprises (SMEs) active in industrial biotechnology in Europe are located in Germany. Alongside these highly dynamic SMEs, several large companies, primarily active in the chemical industry, are also conducting industrial biotechnology R&D in Germany. This high level of activity is a testament to the attractive conditions in Germany.

Currently global revenues for goods produced using industrial biotechnology are estimated between EUR 50 and 60 billion annually. By 2030 this figure is expected to grow to a volume of roughly EUR 300 billion, according to the "Cologne Paper" by the Council of the European Union. Growth projections in Germany are largely based on the country's collective environmental awareness and increasing preference for environmentally-friendly products. At the same time, products manufactured using these new processes promise savings in certain areas, such as production costs and life-cycle assessments. In the case of bioplastics, for example, cost-intensive recycling processes are no longer necessary.

Industrial Biotechnology - Using "Nature's Toolbox"

Industrial biotechnology utilizes "Nature's Toolbox" - microorganisms and enzymes - to create new industrial processes. The chemical industry is currently highly advanced in implementing industrial biotechnology processes, while the food and beverage as well as the pharmaceutical industries are also using this innovative technology. Products include biopolymers (packaging materials), fine and specialty chemicals (amino acids), and consumer goods (detergents and food additives).

Germany Trade & Invest will have industry experts on hand at booth 1200 together with partners from industry and R&D. These partners include industrial biotechnology clusters and companies as well as chemical parks. Industrial biotechnology clusters form a nationwide network working together to accelerate commercialization processes. These clusters represent various players from research institutes and industry. Chemical parks provide a unique flagship model. They offer a full-service infrastructure and enable companies to share overhead and integrate with potential partners. This in turn lowers costs and accelerates the potential for commercialization of new technologies.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

    Germany Trade & Invest
    Eva Henkel
    Email: eva.henkel@gtai.com
    T: +49(0)30-200099-173
    F: +49(0)30-200099-111



'/>"/>
SOURCE Germany Trade and Invest
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
2. World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets
3. Top 10 Drug Delivery Technologies (2010 - 2015): MarketsandMarkets
4. Diabetes Care Devices Market In Brazil, Russia, India, China (BRIC) Worth $570.56 Million In 2014
5. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
6. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
7. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
8. RBC Life Sciences Fills Newly Created Vice President of Sales and Marketing Position With Industry Veteran
9. Highly Regarded Medical Writer Joins Avant Healthcare Marketing Team
10. Healthcare Data Solutions Announces New Healthcare eMarketing Webinar
11. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... PLAINVIEW, N.Y. , Jan. 18, 2017 ... pathology services, announces the formation of an Executive Committee ... 2017 and beyond. John Cucci , ... been promoted from Director of Business Development to ... in 2015, Mr. Cucci served in senior sales leadership ...
(Date:1/18/2017)... Jan. 18, 2017 Applied BioMath ( ... to drug research and development, today announced that ... and CEO of Applied BioMath, will present at ... Modeling (BAGIM) Meeting on Thursday January 19, 2017 ... , MA.   Dr. Burke,s talk "Quantitative Modeling ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker has announced ... and the Department of Defense has announced the award of a new Advanced ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... publishing of the latest paper by its Science Editor, Dr. Elisabeth Bik, in ... voor Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from her previous ...
Breaking Biology Technology:
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
(Date:1/12/2017)... 12, 2017  New research undertaken by Fit Small ... future.  1,000 participants were simply asked which office technology had ... may consider standard issue.  Insights on what will ... gathered from futurists and industry leaders including Penelope Trunk ... .  Some of these findings ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
Breaking Biology News(10 mins):